Market Performance of Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang Pharmaceutical Corp. (ticker 185750.KS) closed its trading session on Wednesday, 21 March 2026, at KRW 66,900, representing a 1.96 % increase compared with the previous close. The price change was recorded at 01:13 AM Central Europe.
Trading Metrics
| Item | Value |
|---|---|
| Current price | KRW 66,900 |
| Trading volume (last 24 h) | KRW 920 million |
| Market capitalisation | KRW 874.9 billion |
| Shares outstanding | 12.9 million |
| 52‑week high | KRW 98,100 (19 Feb 2026) |
| 52‑week low | KRW 63,000 (13 Oct 2026) |
| 200‑day simple moving average | KRW 77,757.5 |
| Performance since month‑end | +4.8 % |
Peer Comparison (last 24 h)
| Company | Ticker | Price | % change | Market cap | P/E ratio |
|---|---|---|---|---|---|
| Hdc | 012630.KS | KRW 20,350 | -0.23 % | KRW 1 trillion | 2.47 |
| Lotte Fine Chemical | 004000.KS | KRW 38,900 | +1.36 % | KRW 1 trillion | 5.64 |
| Dl | 000210.KS | KRW 43,250 | +1.12 % | KRW 1 trillion | 8.95 |
| Hyundai Home Shopping Network | 057050.KS | KRW 87,300 | 0 % | KRW 1 trillion | 9.17 |
Company Overview
Chong Kun Dang Pharmaceutical Corp. is a South Korean healthcare company headquartered in Seoul. Founded in 1941, the company develops, manufactures, and markets prescription drugs for conditions such as hypertension, hyperlipidaemia, diabetes, oncology, and immunosuppression. It also produces health supplements, including prebiotic complexes and omega‑3 formulations, and over‑the‑counter medications such as headache relief, antiparasitic, and menopausal symptom products. The company exports products to the United States and maintains an online presence through its website, www.ckdpharm.com .